首页> 美国卫生研究院文献>BMC Cancer >Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

【2h】

Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

机译：现实世界患者报告的妇女的结果接受初始内分泌疗法的HR + / HER2晚期乳腺癌在五个欧洲国家

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Key characteristics of women with HR+/HER2− advanced breast cancer currently receiving initial endocrine-based therapy for advanced disease: subset of patients providing PRO data

机译：具有HR + / HER2-先进乳腺癌目前接受初始内分泌治疗的女性的关键特征：提供Pro数据的患者患者的子集

著录项

期刊名称 BMC Cancer
作者
Alison Davie; Gebra Cuyun Carter; Alex Rider; James Pike; Katie Lewis; Abigail Bailey; Gregory L. Price; Francois Ringeisen; Xavier Pivot;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 15
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

机译：先进的乳腺癌;与健康有关的生活质量;现实世界的证据;患者报告的结果;
入库时间 2022-08-21 12:06:14

相似文献

外文文献
中文文献
专利

1. Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR /HER2? advanced breast cancer in five European countries [J] . Alison Davie, Gebra Cuyun Carter, Alex Rider, BMC Cancer . 2020,第1期

机译：现实世界患者报告的妇女接受初始内分泌治疗的人力资源/ HER2？五个欧洲国家的晚期乳腺癌
2. AN OUTCOMES MODEL ASSESSING THE IMPACT OF EARLY DISCONTINUATION OF EVEROLIMUS (EVE) DUE TO STOMATITIS ON HEALTH AND PATIENT-REPORTED OUTCOMES IN POSTMENOPAUSAL WOMEN WITH HR+/HER2-ADVANCED BREAST CANCER (ABC) RECEIVING EVEROLIMUS-EXEMESTANE COMBINATION THERAPY (EVE-EXE) [J] . Toram N., Mahjoubi R., Tang D. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：一种结果模型，评估everolimus（前夕）早期停药的影响因患有HR + / Her2晚期乳腺癌（ABC）的绝经后妇女的健康和患者报告的结果（ABC）接受艾莫莫司 - exemestane组合治疗（EVE-EXE）
3. AN OUTCOMES MODEL ASSESSING THE IMPACT OF EARLY DISCONTINUATION OF EVEROLIMUS (EVE) DUE TO STOMATITIS ON HEALTH AND PATIENT-REPORTED OUTCOMES IN POSTMENOPAUSAL WOMEN WITH HR+/HER2-ADVANCED BREAST CANCER (ABC) RECEIVING EVEROLIMUS-EXEMESTANE COMBINATION THERAPY (EVE-EXE) [J] . Toram N., Mahjoubi R., Tang D. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：一种结果模型，评估everolimus（前夕）早期停药的影响因患有HR + / Her2晚期乳腺癌（ABC）的绝经后妇女的健康和患者报告的结果（ABC）接受艾莫莫司 - exemestane组合治疗（EVE-EXE）
4. Elevated WBP2 Expression in HER2-Positive Breast Cancers Correlates with Sensitivity to Trastuzumab-Based Neo-Adjuvant Therapy: A Retrospective and Multicentric Study [C] . Yoon Pin Lim International Molecular Medicine Tri-Conference. . 2019

机译：HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关：回顾性和多中心研究
5. Boron Neutron Capture Therapy for HER2+ breast cancers: A feasibility study evaluating BNCT for potential role in breast conservation therapies. [D] . Jenkins, Peter Anthony. 2012

机译：HER2 +乳腺癌的硼中子捕获疗法：评估BNCT在乳腺癌保护疗法中潜在作用的可行性研究。
6. Real-world clinical profile treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study [O] . A. Davie, G. Cuyun Carter, A. Rider, 2021

机译：具有较差预后因素的HR + / HER2晚期乳腺癌患者的患者的现实世界临床型材治疗模式和患者报告的结果：来自国际研究的数据
7. Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries [O] . Alison Davie, Gebra Cuyun Carter, Alex Rider, 2020

机译：现实世界患者报告的妇女的结果接受初始内分泌疗法的HR + / HER2晚期乳腺癌在五个欧洲国家
8. Phase II Study of a HER-2/neu (HER2) Intracellular Domain (ICD) Peptide- Based Vaccine Administered to Stage IIIB and IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab Monotherapy; Annual rept. 27 Apr 2007-26 Apr 2008 [R] . Disis, M. L. 2008

机译：对接受曲妥珠单抗单一疗法的IIIB和IV期HER2阳性乳腺癌患者施用HER-2 / neu（HER2）细胞内结构域（ICD）基于肽的疫苗的II期研究;年度报告。 2007年4月27日至2008年4月26日

Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

摘要

著录项

相似文献

相关主题

期刊订阅